Abstract
ABSTRACT Infection by some human immunodeficiency virus type 1 (HIV-1) isolates is enhanced by the binding of subneutralizing concentrations of soluble receptor, soluble CD4 (sCD4), or monoclonal antibodies directed against the viral envelope glycoproteins. In this work, we studied the abilities of different antibodies to mediate activation of the envelope glycoproteins of a primary HIV-1 isolate, YU2, and identified the regions of gp120 envelope glycoprotein contributing to activation. Binding of antibodies to a variety of epitopes on gp120, including the CD4 binding site, the third variable (V3) loop, and CD4-induced epitopes, enhanced the entry of viruses containing YU2 envelope glycoproteins. Fab fragments of antibodies directed against either the CD4 binding site or V3 loop also activated YU2 virus infection. The activation phenotype was conferred on the envelope glycoproteins of a laboratory-adapted HIV-1 isolate (HXBc2) by replacing the gp120 V3 loop or V1/V2 and V3 loops with those of the YU2 virus. Infection by the YU2 virus in the presence of activating antibodies remained inhibitable by macrophage inhibitory protein 1β, indicating dependence on the CCR5 coreceptor on the target cells. Thus, antibody enhancement of YU2 entry involves neither Fc receptor binding nor envelope glycoprotein cross-linking, is determined by the same variable loops that dictate enhancement by sCD4, and probably proceeds by a process fundamentally similar to the receptor-activated virus entry pathway.
References
83
Referenced
124
10.1126/science.272.5270.1955
10.1126/science.1925547
10.1126/science.2309120
10.1006/jmbi.1993.1203
10.1126/science.6189183
10.1128/jvi.66.4.2389-2397.1992
- Bugelski P. J. Ellens H. Hart T. K. Kirsh R. L. Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials.J. Acquired Immune Defic. Syndr. 4 1991 923 924 / J. Acquired Immune Defic. Syndr. / Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials by Bugelski P. J. (1991)
10.1073/pnas.88.22.10134
10.1126/science.7973652
10.1006/viro.1993.1664
10.1128/jvi.71.4.2705-2714.1997
10.1016/S0092-8674(00)81313-6
10.1128/jvi.66.6.3531-3537.1992
-
Connor R. I. Dinces N. B. Howell A. L. Romet-Lemonne J. L. Pasquali J. L. Fanger M. W. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.Proc. Natl. Acad. Sci. USA 88 1991 9593 9597
(
10.1073/pnas.88.21.9593
) / Proc. Natl. Acad. Sci. USA / Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R by Connor R. I. (1991) 10.1006/viro.1995.1212
10.1038/381661a0
10.1006/jmbi.1997.0912
10.1016/S0092-8674(00)81314-8
10.1038/381667a0
10.1073/pnas.87.2.648
10.1097/00002030-199305000-00005
10.1016/S0092-8674(00)81393-8
10.1126/science.272.5263.872
10.1128/jvi.66.5.3183-3187.1992
10.1128/jvi.71.4.2779-2785.1997
10.1128/jvi.67.7.3818-3825.1993
10.1016/0092-8674(87)90485-5
10.1089/aid.1989.5.431
10.1126/science.6200936
10.1084/jem.184.6.2433
10.1006/viro.1995.1367
10.1073/pnas.88.6.2189
10.1038/385645a0
10.1128/jvi.64.5.2416-2420.1990
10.1128/jvi.64.12.6314-6318.1990
10.1016/0042-6822(92)90444-T
10.1016/0923-2516(91)90055-8
10.1089/aid.1990.6.1209
10.1128/jvi.68.4.2253-2259.1994
10.1126/science.3629244
10.1128/jvi.66.11.6587-6600.1992
10.1128/jvi.65.8.3973-3985.1991
10.1038/343659a0
10.1128/jvi.69.1.101-109.1995
- Moore J. P. and D. D. Ho. 1995. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS 9 (Suppl. A) : S117–S136.
10.1089/aid.1992.8.443
10.1128/jvi.65.3.1133-1140.1991
10.1126/science.2251501
-
Moore J. P. and P. L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection. AIDS 5 (Suppl. 2) : S21–S33.
(
10.1097/00002030-199101001-00004
) 10.1128/jvi.70.3.1863-1872.1996
10.1089/aid.1997.13.1291
10.1128/jvi.68.8.5264-5269.1994
10.1128/jvi.70.6.3407-3415.1996
10.1159/000319346
10.1128/JVI.72.5.3512-3519.1998
10.1126/science.6200935
10.1089/aid.1987.3.387
10.1128/jvi.62.7.2258-2264.1988
10.1128/jvi.71.4.3219-3227.1997
10.1128/jvi.68.8.4821-4828.1994
10.1084/jem.174.2.407
10.1098/rstb.1993.0136
10.1084/jem.182.1.185
10.1128/jvi.67.12.7383-7393.1993
10.1089/aid.1993.9.159
10.1111/j.1365-3083.1995.tb03528.x
10.1099/0022-1317-78-5-999
10.1016/0161-5890(96)00044-2
10.1128/jvi.70.12.8355-8360.1996
10.1126/science.6204380
10.1006/viro.1997.8443
10.1128/JVI.72.6.4694-4703.1998
10.1128/jvi.69.7.4413-4422.1995
10.1128/jvi.67.6.3674-3679.1993
10.1128/jvi.64.11.5605-5610.1990
10.1128/jvi.66.9.5516-5524.1992
10.1128/jvi.67.7.3978-3988.1993
10.1038/384184a0
10.1073/pnas.85.24.9580
10.1128/jvi.68.2.1029-1039.1994
10.1038/384179a0
10.1128/jvi.69.9.5723-5733.1995
10.1128/jvi.67.8.4557-4565.1993
Dates
Type | When |
---|---|
Created | 5 years, 7 months ago (Dec. 31, 2019, 1:16 p.m.) |
Deposited | 3 years, 5 months ago (March 4, 2022, 10:02 p.m.) |
Indexed | 1 month, 1 week ago (July 14, 2025, 11:26 p.m.) |
Issued | 27 years ago (Aug. 1, 1998) |
Published | 27 years ago (Aug. 1, 1998) |
Published Print | 27 years ago (Aug. 1, 1998) |
@article{Sullivan_1998, title={Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies}, volume={72}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.72.8.6332-6338.1998}, DOI={10.1128/jvi.72.8.6332-6338.1998}, number={8}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Sullivan, Nancy and Sun, Ying and Binley, James and Lee, Juliette and Barbas, Carlos F. and Parren, Paul W. H. I. and Burton, Dennis R. and Sodroski, Joseph}, year={1998}, month=aug, pages={6332–6338} }